Commentary on the Royalty Pharma Ruling of the CJEU of 30 April 2020. Full text: Comunicaciones ENG oct 2020 pag
Recent Posts
- The two-part test for grant of supplementary protection certificates is here to stay, but at what price?26 October 2020
- CEFI Foundation submits its claims to the Draft Reference Price Order 202016 October 2020
- Cefi Foundation’s statements on the action plan to promote the use of drugs regulating the market in the National Health System10 March 2020
- The two-part test for grant of supplementary protection certificates is here to stay, but at what price?